Washington, DC (December 18, 2014) – The National Health Council (NHC) announced that Randy Beranek of Portland, Oregon, will be the 2015 chairperson of the NHC’s Board of Directors. Beranek is the President and Chief Executive Officer of the Portland-based National Psoriasis Foundation (NPF).
National Psoriasis Foundation is the world’s largest nonprofit serving people with psoriasis – the most common autoimmune disease in the country, affecting up to 7.5 million Americans – and psoriatic arthritis, an inflammatory arthritis that occurs in up to 30 percent of people with psoriasis.
The priority of the NPF is to provide people with the information and services they need to take control of their psoriatic disease, while promoting research to find a cure. In addition to serving more than 2.1 million people annually through our health education and advocacy initiatives, the NPF has funded more than $11 million in research grants and fellowships.
Beranek joined the NPF staff in May 2008, bringing with him more than 28 years of executive-level experience in the national, nonprofit health industry. He is past chair of the International Federation of Psoriasis Associations General Assembly. Prior to joining NPF, Randy spent more than 13 years with the American Diabetes Association.
In the coming year, the priority issues for the NHC will include:
- Championing health insurance marketplace improvements, conducting a state-by-state analysis of how “patient friendly” the exchange requirements are, and educating people with chronic conditions about picking the right exchange plan by promoting an online out-of-pocket health costs calculator at www.puttingpatientsfirst.net.
- Encouraging the development of new treatments and diagnostic tools for people with chronic conditions through passage of the MODDERN Cures Act.
- Serving as the united patient voice before the bipartisan 21st Century Cures initiative, spearheaded by the House Energy and Commerce Committee, to ensure Congress addresses the unmet medical needs of patients, increases patient engagement in the drug development continuum, and improves data sharing to make knowledge gleaned at the point-of-care more available to researchers.
The NHC is the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers. Made up of more than 100 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient advocacy organizations, which control its governance. Other members include professional and membership associations, nonprofit organizations with an interest in health, and major pharmaceutical, medical device, health insurance, and biotechnology companies. Visit www.nationalhealthcouncil.org to learn more.